Please sign in to follow a disease.
Overnutrition
MONDO:0003916An imbalanced nutritional status resulting from excessive intake of nutrients. Generally, overnutrition generates an energy imbalance between food consumption and energy expenditure leading to disorders such as obesity.
3247 clinical trials for this condition and its sub-types, 15 tagged with Overnutrition itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Overnutrition
-
Obesity disorder 2,907 trials · 3,019 incl. sub-types
2 sub-types
- Morbid obesity 224 trials
- Inherited obesity 8 trials · 9 incl. sub-types Sub-types →
-
Abdominal obesity-metabolic syndrome 301 trials · 357 incl. sub-types
5 sub-types
- Metabolic syndrome X 338 trials
- LIPE-related familial partial lipodystrophy 0 trials
- Abdominal obesity-metabolic syndrome 3 0 trials
- Abdominal obesity-metabolic syndrome 4 0 trials
- Abdominal obesity-metabolic syndrome quantitative trait locus 2 0 trials
-
Hypervitaminosis A 0 trials
-
Hypervitaminosis D 0 trials
Most studied deeper sub-types
-
New program helps hispanic moms and kids get healthy together
Disease control CompletedThis study tested a 12-week program for Hispanic mothers with overweight or obesity and their 3-5 year old children. The program included weekly classes on nutrition, exercise, and coping skills, plus exercise sessions. Researchers measured changes in weight, body fat, and health…
Sponsor: University of Miami • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New Weight-Loss drug shows promise in early trial
Disease control CompletedThis phase 2 study tested a new drug called eloralintide (LY3841136) for weight management in 263 adults with obesity or overweight. Participants received either the drug or a placebo for about 64 weeks. The main goal was to see how much weight they lost after 48 weeks. Results w…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New weight loss drug shows promise in early trial
Disease control CompletedThis study tested a new drug called Mazdutide to help adults with obesity or overweight lose weight. 179 participants took either the drug or a placebo for about 62 weeks. The main goal was to see how much weight they lost after 32 weeks, with a focus on safety and effectiveness.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
What makes us overeat? new study probes Obesity's hidden triggers
Knowledge-focused CompletedThis completed study investigated how eating behaviors and food preferences, especially for high-fat foods, contribute to obesity. Researchers studied 669 healthy adults, including Pima Indians (who have high obesity rates) and Caucasians, using questionnaires and food intake mea…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC